Abigail (Lauterbach) Schmitz
Senior Associate
RA Capital Management
TechAtlas senior associate evaluating biotech opportunities and competitive landscapes.
Bio
Professional summary
Laura Tadvalkar is a Managing Director on RA Capital's Venture Team, where she works on new company creation and early-stage investments. She serves as a board director for Be Biopharma, Hemab, Hyku Biosciences, and Typewriter Therapeutics, and previously served on the board of Mariana Oncology before its acquisition by Novartis and as board chair of Aliada Therapeutics before its acquisition by AbbVie. Before RA Capital, she was a Principal at MP Healthcare Venture Management and a Consultant at Clarion Healthcare.
Notable companies
Selected portfolio companies the partner has backed
Be BiopharmaHemabHyku BiosciencesTypewriter TherapeuticsMariana OncologyAliada Therapeutics
Background
Career, education, and skills
Career history
- RA Capital ManagementManaging DirectorPresent
- MP Healthcare Venture ManagementPrincipal
- Clarion HealthcareConsultant
Education
- Yale UniversityBS in Chemistry
- Harvard UniversityPhD in Chemical Biology
Other partners at RA Capital Management
12 more profiles
Adam Prince, MD
Senior Associate, Strategic Initiatives
RA Capital Management
RA Capital TechAtlas senior associate with cardiology and medical training.
Alana MacDonald, Ph.D.
Senior Associate
RA Capital Management
Senior TechAtlas associate focused on biotech diligence, landscapes, and portfolio strategy.
Alejandro Sevilla
Associate
RA Capital Management
Planetary Health associate focused on climate-tech landscapes and investment evaluation.
Alex Miller
Senior Associate, Venture
RA Capital Management
Venture senior associate focused on biotech diligence and portfolio strategy.
Alex T. Zhang
Vice President, Structured Capital
RA Capital Management
Structured Capital VP focused on healthcare and life-sciences credit investments.
Alexander Martinez-Forte
Director, Quantitative Research & Strategy
RA Capital Management
RA Capital director leading quantitative analyses for investment decisions and portfolio management.
Allison Harrigan
Senior Director Corporate Development
RA Capital Management
Raven corporate development leader focused on biotech company creation.
Alyssa Larson
Director, Healthcare Specialist - Investor Relations
RA Capital Management
TechAtlas director supporting healthcare diligence and investor relations.
Ami Thakrar, PhD
Associate
RA Capital Management
TechAtlas associate focused on biotech diligence and program strategy.
Anish K. More
Vice President, Corporate Development
RA Capital Management
Raven corporate-development VP focused on investment evaluation and NewCo creation.
Anurag Kondapalli
Principal
RA Capital Management
Principal investing across public and private healthcare technology and services companies.